onyx pharmaceuticals inc
(ONXX:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
Earnings & Estimates Summary - ONYX PHARMACEUTICALS INC (ONXX)
2012 revenues at Onyx Pharmaceuticals, Inc. totaled $362.2M USD, while annual losses equaled $2.50 per share.
Quarterly Earnings & Estimates - ONYX PHARMACEUTICALS INC (ONXX)
51.65%
Onyx Pharmaceuticals, Inc.'s Quarterly Earnings
Onyx Pharmaceuticals, Inc. reported 1st quarter 2013 losses of $0.19 per share on 05/9/2013.
Annual Earnings & Estimates - ONYX PHARMACEUTICALS INC (ONXX)
Onyx Pharmaceuticals, Inc.'s Annual Earnings
Onyx Pharmaceuticals, Inc. reported annual 2012 losses of $2.50 per share on 02/23/2013.
Quarterly Revenues - ONYX PHARMACEUTICALS INC (ONXX)
Onyx Pharmaceuticals, Inc.'s Quarterly Revenues
Onyx Pharmaceuticals, Inc. had 1st quarter 2013 revenues of $145.5M USD. This bettered the $134.9M USD consensus of the 16 analysts covering the company. This was 102.0% above the prior year's 1st quarter results.
Annual Revenues - ONYX PHARMACEUTICALS INC (ONXX)
Onyx Pharmaceuticals, Inc.'s Annual Revenues
Onyx Pharmaceuticals, Inc. had revenues for the full year 2012 of $362.2M USD. This was -19.0% below the prior year's results.
| Recently Viewed | |||
| ONXX:US | $95.65 USD | +0.30 |  |
| Company | Last | Change |
| Alkermes PLC | $31.69 USD | +1.36 |
| BioMarin Pharmaceutical Inc | $64.01 USD | -0.49 |
| Incyte Corp Ltd | $23.04 USD | -0.13 |
| Jazz Pharmaceuticals Plc | $58.36 USD | +0.04 |
| Pharmacyclics Inc | $84.89 USD | +0.97 |
| View Industry Companies | ||
Industry Analysis
ONXX
Industry Average
| Valuation | ONXX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 15.6x |
|
| Price/Book | 6.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 13.8x |
|
Post a JobJobs
- South San Francisco, CA | Onyx PharmaceuticalsPosted: May 13
- South San Francisco, CA | Onyx PharmaceuticalsPosted: May 17
- South San Francisco, CA | Onyx PharmaceuticalsPosted: May 16
- South San Francisco, CA | Onyx PharmaceuticalsPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
To contact ONYX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
